Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 1,131,500 | 1,131,500 | 0 | $80.39M | $80.21M | 22.04% | -$181.0K |
| UroGen Pharma Ltd.(URGN) | 1,673,420 | 1,648,420 | -25,000 | $61.58M | $66.98M | 18.40% | +$5.39M |
| Puma Biotechnology Inc | 4,131,299 | 4,131,299 | 0 | $33.50M | $41.02M | 11.27% | +$7.52M |
| Candel Therapeutics Inc | 3,497,948 | 3,497,948 | 0 | $36.03M | $36.52M | 10.03% | +$489.7K |
| Trevi Therapeutics, Inc.(TRVI) | 2,144,844 | 2,144,844 | 0 | $40.00M | $30.71M | 8.44% | -$9.29M |
| Helus Pharma Inc. | 1,540,266 | 1,540,266 | 0 | $10.18M | $18.93M | 5.20% | +$8.75M |
| Jade Biosceinces Inc | 986,760 | 986,760 | 0 | $21.93M | $13.86M | 3.81% | -$8.06M |
| Bicara Therapeutics | 643,381 | 668,381 | +25,000 | $19.10M | $12.44M | 3.42% | -$6.66M |
| Verastem, Inc.(VSTM) | 1,469,153 | 1,469,153 | 0 | $5.61M | $11.83M | 3.25% | +$6.21M |
| Onkure Therapeutics IncCL A | 2,839,674 | 2,839,674 | 0 | $12.95M | $7.75M | 2.13% | -$5.20M |
| Eugene Therapeutics | 1,271,257 | 3,811,782 | +2,540,525 | $2.20M | $7.62M | 2.09% | +$5.42M |
| An2 Therapeutics | 0 | 1,300,000 | +1,300,000 | $0 | $6.92M | 1.90% | +$6.92M |
| Aura Biosciences Inc | 929,077 | 1,025,349 | +96,272 | $6.60M | $6.44M | 1.77% | -$157.3K |
| Protara Therapeutics Inc | 1,752,115 | 1,752,115 | 0 | $6.69M | $5.34M | 1.47% | -$1.35M |
| Annexon Inc. | 0 | 1,136,974 | +1,136,974 | $0 | $4.81M | 1.32% | +$4.81M |
| Leonabio, Inc. | 634,539 | 1,144,416 | +509,877 | $5.83M | $4.09M | 1.12% | -$1.75M |
| Whitehawk Therapeutics Inc | 1,139,363 | 932,139 | -207,224 | $5.22M | $3.50M | 0.96% | -$1.71M |
| Q32 Bio Inc. | 216,171 | 216,171 | 0 | $2.75M | $1.79M | 0.49% | -$966.3K |
| Karyopharm Therapeutics Inc | 1,518,113 | 1,222,019 | -296,094 | $14.83M | $1.49M | 0.41% | -$13.34M |
| Jasper Therapeutics | 1,438,159 | 1,438,159 | 0 | $604.0K | $834.1K | 0.23% | +$230.1K |
| Yarrow Biosciences Inc | 1,425 | 32,005 | +30,580 | $926 | $720.7K | 0.20% | +$719.8K |
| Bioatla Inc | 108,126 | 108,127 | +1 | $447.6K | $140.6K | 0.04% | -$307.1K |